These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 21403605)
1. Tumor microenvironment and progression of pancreatic cancer. Erkan M; Reiser-Erkan C; Michalski CW; Kleeff J Exp Oncol; 2010 Sep; 32(3):128-31. PubMed ID: 21403605 [TBL] [Abstract][Full Text] [Related]
2. The role of the tumor microenvironment in the progression of pancreatic cancer. Farrow B; Albo D; Berger DH J Surg Res; 2008 Oct; 149(2):319-28. PubMed ID: 18639248 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of disease: chronic inflammation and cancer in the pancreas--a potential role for pancreatic stellate cells? Algül H; Treiber M; Lesina M; Schmid RM Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):454-62. PubMed ID: 17667994 [TBL] [Abstract][Full Text] [Related]
4. Hedgehog signaling and pancreatic tumor development. Lauth M; Toftgård R Adv Cancer Res; 2011; 110():1-17. PubMed ID: 21704226 [TBL] [Abstract][Full Text] [Related]
7. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer. Roda O; Ortiz-Zapater E; Martínez-Bosch N; Gutiérrez-Gallego R; Vila-Perelló M; Ampurdanés C; Gabius HJ; André S; Andreu D; Real FX; Navarro P Gastroenterology; 2009 Apr; 136(4):1379-90, e1-5. PubMed ID: 19171142 [TBL] [Abstract][Full Text] [Related]
8. The microenvironment in chronic pancreatitis and pancreatic cancer induces neuronal plasticity. Demir IE; Ceyhan GO; Rauch U; Altintas B; Klotz M; Müller MW; Büchler MW; Friess H; Schäfer KH Neurogastroenterol Motil; 2010 Apr; 22(4):480-90, e112-3. PubMed ID: 19912545 [TBL] [Abstract][Full Text] [Related]
9. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641 [TBL] [Abstract][Full Text] [Related]
10. New insights into alcoholic pancreatitis and pancreatic cancer. Apte M; Pirola R; Wilson J J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S51-6. PubMed ID: 19799699 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Hiraoka N; Onozato K; Kosuge T; Hirohashi S Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD90 (Thy-1) in pancreatic adenocarcinoma present in the tumor microenvironment. Zhu J; Thakolwiboon S; Liu X; Zhang M; Lubman DM PLoS One; 2014; 9(12):e115507. PubMed ID: 25536077 [TBL] [Abstract][Full Text] [Related]
14. Tumor-derived pancreatic stellate cells promote pancreatic cancer cell invasion through release of thrombospondin-2. Farrow B; Berger DH; Rowley D J Surg Res; 2009 Sep; 156(1):155-60. PubMed ID: 19592030 [TBL] [Abstract][Full Text] [Related]
15. S100P is an early developmental marker of pancreatic carcinogenesis. Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674 [TBL] [Abstract][Full Text] [Related]
16. The role of pancreatic stellate cells in pancreatic cancer. Erkan M Pancreatology; 2013; 13(2):106-9. PubMed ID: 23561966 [TBL] [Abstract][Full Text] [Related]
17. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer. Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968 [TBL] [Abstract][Full Text] [Related]
18. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Määttä M; Soini Y; Liakka A; Autio-Harmainen H Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717 [TBL] [Abstract][Full Text] [Related]